Cargando…
Foscan® uptake and tissue distribution in relation to photodynamic efficacy
Clinical photodynamic therapy (PDT) schedules are based on the assumption that optimum drug–light intervals are times at which there is a maximum differential between photosensitiser retention in the tumour and surrounding normal tissue. However, vascular-mediated effects contribute to tumour destru...
Autores principales: | Cramers, P, Ruevekamp, M, Oppelaar, H, Dalesio, O, Baas, P, Stewart, F A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377038/ https://www.ncbi.nlm.nih.gov/pubmed/12610515 http://dx.doi.org/10.1038/sj.bjc.6600682 |
Ejemplares similares
-
Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003) -
Uptake and localisation of mTHPC (Foscan®) and its(14)C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study
por: Blant, S Andrejevic, et al.
Publicado: (2002) -
Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
por: Teiten, M-H, et al.
Publicado: (2003) -
Relationship between subcellular localisation of Foscan® and caspase activation in photosensitised MCF-7 cells
por: Marchal, S, et al.
Publicado: (2007) -
Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)